Related references
Note: Only part of the references are listed.Patient and Disease-Specific Induced Pluripotent Stem Cells for Discovery of Personalized Cardiovascular Drugs and Therapeutics
David T. Paik et al.
PHARMACOLOGICAL REVIEWS (2020)
Cryopreservation of human pluripotent stem cell-derived cardiomyocytes is not detrimental to their molecular and functional properties
Lettine van den Brink et al.
STEM CELL RESEARCH (2020)
A Human iPSC Double-Reporter System Enables Purification of Cardiac Lineage Subpopulations with Distinct Function and Drug Response Profiles
Joe Z. Zhang et al.
CELL STEM CELL (2019)
Human-Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Patients With Breast Cancer
Tomoya Kitani et al.
CIRCULATION (2019)
Identifying the Transcriptome Signatures of Calcium Channel Blockers in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Chi Keung Lam et al.
CIRCULATION RESEARCH (2019)
Determining the Pathogenicity of a Genomic Variant of Uncertain Significance Using CRISPR/Cas9 and Human-Induced Pluripotent Stem Cells
Ning Ma et al.
CIRCULATION (2018)
Applications of genetically engineered human pluripotent stem cell reporters in cardiac stem cell biology
Joe Z. Zhang et al.
CURRENT OPINION IN BIOTECHNOLOGY (2018)
Electrophysiologic Characterization of Calcium Handling in Human Induced Pluripotent Stem Cell-Derived Atrial Cardiomyocytes
Mariana Argenziano et al.
STEM CELL REPORTS (2018)
Comparison of Non-human Primate versus Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Treatment of Myocardial Infarction
Xin Zhao et al.
STEM CELL REPORTS (2018)
International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment
Ksenia Blinova et al.
CELL REPORTS (2018)
Experimentally Validated Pharmacoinformatics Approach to Predict hERG Inhibition Potential of New Chemical Entities
Saba Munawar et al.
FRONTIERS IN PHARMACOLOGY (2018)
Development of a Human iPSC Cardiomyocyte-Based Scoring System for Cardiac Hazard Identification in Early Drug Safety De-risking
Ivan Kopljar et al.
STEM CELL REPORTS (2018)
Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias
Ksenia Blinova et al.
TOXICOLOGICAL SCIENCES (2017)
CSAHi study-2: Validation of multi-electrode array systems (MEA60/2100) for prediction of drug-induced proarrhythmia using human iPS cell-derived cardiomyocytes: Assessment of reference compounds and comparison with non-clinical studies and clinical information
Yumiko Nozaki et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2017)
Proarrhythmia liability assessment and the comprehensive in vitro Proarrhythmia Assay (CiPA): An industry survey on current practice
Simon Authier et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2017)
A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes
Hiroyuki Ando et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2017)
Chronic drug-induced effects on contractile motion properties and cardiac biomarkers in human induced pluripotent stem cell-derived cardiomyocytes
Ivan Kopljar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
WITHDRAWN-a resource for withdrawn and discontinued drugs
Vishal B. Siramshetty et al.
NUCLEIC ACIDS RESEARCH (2016)
Induced pluripotent stem cells: at the heart of cardiovascular precision medicine
Ian Y. Chen et al.
NATURE REVIEWS CARDIOLOGY (2016)
The Use of Ratiometric Fluorescence Measurements of the Voltage Sensitive Dye Di-4-ANEPPS to Examine Action Potential Characteristics and Drug Effects on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
M. P. Hortigon-Vinagre et al.
TOXICOLOGICAL SCIENCES (2016)
The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative Update on progress
Thomas Colatsky et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2016)
Comparable calcium handling of human iPSC-derived cardiomyocytes generated by multiple laboratories
Hyun Seok Hwang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Development of a scalable suspension culture for cardiac differentiation from human pluripotent stem cells
Vincent C. Chen et al.
STEM CELL RESEARCH (2015)
Immaturity of Human Stem-Cell-Derived Cardiomyocytes in Culture: Fatal Flaw or Soluble Problem?
Christiaan C. Veerman et al.
STEM CELLS AND DEVELOPMENT (2015)
Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium
Philip T. Sager et al.
AMERICAN HEART JOURNAL (2014)
Image-based evaluation of contraction-relaxation kinetics of human-induced pluripotent stem cell-derived cardiomyocytes: Correlation and complementarity with extracellular electrophysiology
Tomohiro Hayakawa et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Chemically defined generation of human cardiomyocytes
Paul W. Burridge et al.
NATURE METHODS (2014)
Comprehensive Analyses of Ventricular Myocyte Models Identify Targets Exhibiting Favorable Rate Dependence
Megan A. Cummins et al.
PLOS COMPUTATIONAL BIOLOGY (2014)
Refining the Human iPSC-Cardiomyocyte Arrhythmic Risk Assessment Model
Liang Guo et al.
TOXICOLOGICAL SCIENCES (2013)
Phenotypic Profiling of Structural Cardiotoxins In Vitro Reveals Dependency on Multiple Mechanisms of Toxicity
Amy Pointon et al.
TOXICOLOGICAL SCIENCES (2013)
Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts
Yuji Shiba et al.
NATURE (2012)
High throughput measurement of Ca2+ dynamics for drug risk assessment in human stem cell-derived cardiomyocytes by kinetic image cytometry
Fabio Cerignoli et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2012)
Alternans and Arrhythmias From Cell to Heart
James N. Weiss et al.
CIRCULATION RESEARCH (2011)
Efficient generation and cryopreservation of cardiomyocytes derived from human embryonic stem cells
Chunhui Xu et al.
REGENERATIVE MEDICINE (2011)
Cryopreservation of Human Embryonic Stem Cells Derived-Cardiomyocytes Induced by BMP2 in Serum-Free Condition
Yoon Young Kim et al.
REPRODUCTIVE SCIENCES (2011)
Reverse rate-dependent changes are determined by baseline action potential duration in mammalian and human ventricular preparations
Laszlo Barandi et al.
BASIC RESEARCH IN CARDIOLOGY (2010)
Drug-induced changes in action potential duration are proportional to action potential duration in rat ventricular myocardium
Laszlo Barandi et al.
GENERAL PHYSIOLOGY AND BIOPHYSICS (2010)
Share Paper
